Home based tuberculosis (TB) care program Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014
Interpretation of indeterminate RIF-susceptibility results obtained by rapid molecular diagnostics test Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016
Gene-Xpert for rapid detection of MDR-TB in re-treatment cases;a comparison with standard culture and DST Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015
Four cases, one family: A cluster of resistant tuberculosis Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
Evaluation of a tuberculosis control programme based on case-finding Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013
Management of tuberculosis (TB) at a district general hospital: An audit of practice Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013
Implementation of rapid drug-susceptibility testing for patients at high risk of multidrug-resistant tuberculosis in Cambodia Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
Using results of new laboratory test for tuberculosis infection in children Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
The top of the iceberg - Extensively drug resistant tuberculosis (XDR-TB) in 2010 Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015
Clinical profile of MDR-TB patients and their early response to DOTS PLUS: An Indian perspective Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013
Diagnostic yield of AFB smear, culture, LiPA, GeneXpert: A clinician’s perspective Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015
MDR TB treatment results of GFATM program implementation in Tomsk, Russia Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia) Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Comparision of line probe assay and conventional methos for detection of mycobacteria other than tuberculosis (MOTT) strains from patients suferring from pulmonary tuberculosis Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) Year: 2016
The effectiveness of programmatic management of latent tuberculosis infection in the Netherlands Source: International Congress 2015 – Latent TB infection and screening Year: 2015
Evaluating 17 years of LTBI screening in NW England Source: International Congress 2016 – Latent tuberculosis infection Year: 2016
Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016
Notified or missed cases? An assessment of successful linkage for referred tuberculosis patients in South India Source: International Congress 2015 – Case series and clinical conundrums in TB Year: 2015
Influence of early diagnostics with Xpert MTB/RIF on MDR TB patients treatment efficacy Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015
Rapid monitoring of tuberculosis treatment response: A multi-centre study Source: International Congress 2016 – Advances in tuberculosis diagnosis and monitoring of treatment Year: 2016